tiprankstipranks
Innoviva Updates Investor Presentation on Website
PremiumCompany AnnouncementsInnoviva Updates Investor Presentation on Website
2M ago
INVA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
INVA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Innoviva: trial data for uncomplicated gonorrhea treatment presented at ESCMI
PremiumThe Fly
Innoviva: trial data for uncomplicated gonorrhea treatment presented at ESCMI
3M ago
INVA Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsINVA Upcoming Earnings Report: What to Expect?
9M ago
Innoviva names Stephen Basso as CFO, effective August 21
PremiumThe Fly
Innoviva names Stephen Basso as CFO, effective August 21
11M ago
Innoviva reports Q2 EPS 2c, revenue of $80.99M
PremiumThe Fly
Innoviva reports Q2 EPS 2c, revenue of $80.99M
12M ago
Innoviva Rises on Advisory Committee Backing for Bacterial Pneumonia Therapy
PremiumMarket NewsInnoviva Rises on Advisory Committee Backing for Bacterial Pneumonia Therapy
1y ago
Innoviva’s sulbactam-durlobactam recommended for approval by FDA panel
PremiumThe Fly
Innoviva’s sulbactam-durlobactam recommended for approval by FDA panel
1y ago
Innoviva announces FDA AdCom meeting to review Sulbactam-Durlobactam
PremiumThe Fly
Innoviva announces FDA AdCom meeting to review Sulbactam-Durlobactam
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100